ARCHIVES

In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

Professional Fundraiser Poses Eight Questions For SU2C 3.

September 19, 2008

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants

February 14, 1992

DRCCA Board Approves Concepts Of Four New Antismoking Projects

May 20, 1983

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013